Adalimumab‐responsive Monogenic Inflammatory Bowel Disease With Pseudopolyposis Characteristic of TGFBR2 Variant in Loeys‐Dietz Syndrome. The gene discussed is TGFBR2; the disease is inflammatory bowel disease.